- Professor of Clinical Neuroscience at the Neurology Research and Clinical Trials Unit of the Peninsula Medical School at the University of Plymouth
- Not Clearly Pro or Con to the question "Should Marijuana Be a Medical Option?"
“I very much welcome any potential change to the law, providing the results of the clinical trials are positive. Some patients have already reported an improvement in pain but it is too early to draw any conclusions…
If we are to provide the evidence that the drug is useful in alleviating pain in MS then there has to be a way of getting the drug to those patients. Changes in the classification of cannabis would help for that to be achieved and that is a good thing.”
“Medicinal Cannabis Set to be Legalised” Oct. 23, 2001
- Theoretical Expertise Ranking:
Individuals with MDs, PhDs, JDs, or equivalent advanced degrees in fields relevant to medical marijuana. Also top-level government officials (such as foreign leaders, US presidents, Founding Fathers, Supreme Court Justices, members of legislative bodies, cabinet members, military leaders, etc.) with positions relevant to medical marijuana issues.
- Involvement and Affiliations:
- Professor of Clinical Neuroscience, Neurology Research and Clinical Trials Unit, Peninsula Medical School, University of Plymouth, UK
- Consultant Neurologist, Derriford Hospital, Plymouth, UK
- Principle Investigator, Cannabinoids in Multiple Sclerosis (CAMS)
- Principle Investigator, South West Impact of Multiple Sclerosis (SWIMS)
- PhD, School unknown
- Fellowship of the Royal College of Physicians (FRCP)
- None found